PRIMARY STUDY

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Key Findings:  Resulting data revealed that BCP reduces METH reward, METH intake, and motivation to seek and take METH via via modulation of both CB2- and non-CB2-dependent mechanisms.

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  China, United States

Year of Pub:  2021


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene

Receptors Studied:  CB2

Route of Administration:  Injection



Link to study